The Effect of BIIL 284 BS on Induced-sputum Variables in Patients With Bronchial Asthma
NCT02249312
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
38
Enrollment
INDUSTRY
Sponsor class
Conditions
Asthma
Interventions
DRUG:
BIIL 284 BS
DRUG:
Placebo
Sponsor
Boehringer Ingelheim